Perrigo (PRGO) Net Income Growth (5y) (2017 - 2026)
Perrigo (PRGO) Net Income Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Perrigo | 1.44 Bn | 1.08 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -17.57% |
| Dec 31, 2025 | 50.91% |
| Sep 27, 2025 | 50.83% |
| Jun 28, 2025 | -16.69% |
| Mar 29, 2025 | -16.36% |
| Dec 31, 2024 | 14.06% |
| Sep 28, 2024 | -15.29% |
| Jun 29, 2024 | -18.13% |
| Mar 30, 2024 | -15.24% |
| Dec 31, 2023 | -15.51% |
| Sep 30, 2023 | 55.33% |
| Jul 1, 2023 | -15.03% |
| Apr 1, 2023 | -15.14% |
| Dec 31, 2022 | -16.55% |
| Oct 1, 2022 | -42.90% |
| Jul 2, 2022 | 68.98% |
| Apr 2, 2022 | -15.05% |
| Dec 31, 2021 | 55.97% |
| Oct 2, 2021 | 68.41% |
| Apr 3, 2021 | 15.63% |